Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.

Cancer research | Nov 1, 2011

ARID1A (BAF250A) promotes the formation of SWI/SNF chromatin remodeling complexes containing BRG1 or BRM. It has emerged as a candidate tumor suppressor based on its frequent mutations in ovarian clear cell and endometrioid cancers and in uterine endometrioid carcinomas. Here, we report that restoring wild-type ARID1A expression in ovarian cancer cells that harbor ARID1A mutations is sufficient to suppress cell proliferation and tumor growth in mice, whereas RNA interference-mediated silencing of ARID1A in nontransformed epithelial cells is sufficient to enhance cellular proliferation and tumorigenicity. Gene expression analysis identified several downstream targets of ARID1A including CDKN1A and SMAD3, which are well-known p53 target genes. In support of the likelihood that p53 mediates the effects of ARID1A on these genes, we showed that p53 was required and sufficient for their regulation by ARID1A. Furthermore, we showed that CDKN1A (encoding p21) acted in part to mediate growth suppression by ARID1A. Finally, we obtained evidence that the ARID1A/BRG1 complex interacted directly with p53 and that mutations in the ARID1A and TP53 genes were mutually exclusive in tumor specimens examined. Our results provide functional evidence in support of the hypothesis that ARID1A is a bona fide tumor suppressor that collaborates with p53 to regulate CDKN1A and SMAD3 transcription and tumor growth in gynecologic cancers.

Pubmed ID: 21900401 RIS Download

Mesh terms: Adenocarcinoma, Clear Cell | Animals | Cell Line, Tumor | Chromatin Assembly and Disassembly | Cyclin-Dependent Kinase Inhibitor p21 | DNA Helicases | Epithelial Cells | Female | Gene Expression Regulation, Neoplastic | Genetic Complementation Test | Humans | Mice | Mice, Nude | Multiprotein Complexes | Mutation | Neoplasm Proteins | Neoplasm Transplantation | Nuclear Proteins | Ovarian Neoplasms | Promoter Regions, Genetic | Recombinant Fusion Proteins | Smad3 Protein | Transcription Factors | Tumor Suppressor Protein p53 | Tumor Suppressor Proteins | p21-Activated Kinases

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NCI NIH HHS, Id: CA103937
  • Agency: NCI NIH HHS, Id: CA129080
  • Agency: NCI NIH HHS, Id: R01 CA129080-05
  • Agency: NCI NIH HHS, Id: R01 CA129080
  • Agency: NCI NIH HHS, Id: R01 CA103937
  • Agency: NCI NIH HHS, Id: R01 CA103937-08

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.